Pura Vida Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-23,200
Closed -$5.89M 265
2021
Q4
$5.89M Buy
+23,200
New +$6.78M 0.21% 105
2021
Q2
Sell
-50,600
Closed -$6.63M 262
2021
Q1
$6.63M Buy
+50,600
New +$7.33M 0.19% 103

Other funds holding MRNA

Pura Vida Investments's MRNA Position: Q2 2021 in Review

Pura Vida Investments sold out of Moderna (MRNA) in Q2 2021, closing a stake of 26,791 shares — an estimated $3.51M sold.

Pura Vida Investments first reported a position in MRNA in Q1 2021 and held it in 1 quarter. The position peaked at $3.51M in Q1 2021. 904 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • Pura Vida Investments reported no remaining Moderna position as of Q2 2021 after selling out during the quarter.
  • Pura Vida Investments sold 26,791 Moderna shares in Q2 2021, an estimated $3.51M.
  • Pura Vida Investments first reported a position in Moderna in Q1 2021 and held it in 1 quarter.
  • Pura Vida Investments's Moderna position peaked at $3.51M in Q1 2021.
  • 904 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.